Neovasc Stock Price, News & Analysis (TSE:NVC) Add Share Share Today's Range N/A50-Day RangeC$1.78▼C$1.7852-Week Range N/AVolume46,869 shsAverage Volume111,876 shsMarket CapitalizationC$140.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A About Neovasc Stock (TSE:NVC)Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.Read More NVC Stock News HeadlinesNovember 9, 2023 | finance.yahoo.comNew Shockwave Coronary IVL Publication Shows Similar Outcomes in Women And MenNovember 3, 2023 | markets.businessinsider.comCenters for Medicare & Medicaid Services Establishes New Category I CPT® Add-On Code for Coronary IVLDecember 6, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comOctober 26, 2023 | benzinga.comShockwave Medical Announces Details for Conference Call Discussing Third Quarter 2023 Results and Participation in Upcoming Investor ConferenceOctober 10, 2023 | msn.comHaemonetics Corp. Acquires Quebec’s OpSens Inc. in Major Medical Tech DealSeptember 12, 2023 | finanznachrichten.deShockwave Medical, Inc.: Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024September 11, 2023 | finance.yahoo.comShockwave Medical Announces Dan Puckett to Retire as CFO in 2024August 19, 2023 | forbes.comConvert NovaCoin To Canadian DollarDecember 6, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comJuly 3, 2023 | benzinga.comHeart Valve Devices Market to Cross USD 8.7 billion in 2031, expanding at a CAGR of 11.9%: TMR ReportJune 14, 2023 | forbes.comConvert NovaCoin To United States DollarJune 14, 2023 | forbes.comConvert NovaCoin To Sri Lankan RupeeJune 10, 2023 | forbes.comConvert NovaCoin To Mexican PesoJune 10, 2023 | forbes.comConvert NovaCoin To Chinese Yuan (Offshore)May 23, 2023 | forbes.comConvert NovaCoin To BitcoinMay 21, 2023 | forbes.comConvert NovaCoin To EthereumMay 20, 2023 | forbes.comConvert NovaCoin To EuroMay 18, 2023 | forbes.comConvert NovaCoin To Ukrainian HryvniaMay 17, 2023 | forbes.comConvert NovaCoin To Georgian LariMay 17, 2023 | forbes.comConvert NovaCoin To Iraqi DinarSeptember 15, 2022 | investing.comNVC Lighting Holding Ltd (2222)October 18, 2021 | stockhouse.comTherma Bright Inc V.THRMAugust 30, 2021 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright & Co. 23rd Annual Global Investment ConferenceAugust 19, 2021 | finanznachrichten.deNeovasc Inc.: Neovasc Announces Submission of COSIRA-II Protocol Supplement to FDAAugust 17, 2021 | finance.yahoo.comNeovasc Announces Submission of COSIRA-II Protocol Supplement to FDAAugust 10, 2021 | finanznachrichten.deNeovasc Inc.: Neovasc Announces Second Quarter 2021 Financial ResultsAugust 1, 2021 | markets.businessinsider.comSheng Siong to buy New World Centre strata unit from TA Corp for S$17.25 millionSee More Headlines Receive NVC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolTSE:NVC CUSIPN/A CIKN/A Webwww.neovasc.com Phone+1-604-2704344FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares78,683,000Free FloatN/AMarket CapC$140.06 million OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesPaul L. GeyerIndependent Chairman of the BoardFred ColenPresident, Chief Executive OfficerChristopher ClarkChief Financial Officer, Corporate SecretaryBrian McPhersonChief Operating OfficerVicki Lee BebeauVice President - Clinical AffairsRandy LaneVice President - Research & DevelopmentAlexei J. MarkoDirectorJane H. Hsiao Ph.D. (Age 69)Independent Director Douglas Glen JanzenIndependent DirectorWilliam O'Neill (Age 61)Independent Director More Executives NVC Stock Analysis - Frequently Asked Questions Should I buy or sell Neovasc stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVC, but not buy additional shares or sell existing shares. View NVC analyst ratings or view top-rated stocks. What other stocks do shareholders of Neovasc own? Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Neovasc (NVCN), PPL (PPL), Ballard Power Systems (BLDP), (CPXX) (CPXX), 155675 (BLD.TO) (BLD), Dundee Precious Metals (DPM), Fc Global Realty (FCRE), Top Ships (TOPS) and Birchcliff Energy (BIR). How do I buy shares of Neovasc? Shares of NVC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVC) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.